Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 170

1.

Urologic Disorders are Still the Leading Cause of In-hospital Death in Patients With Spina Bifida.

Peyronnet B, Gao F, Brochard C, Oger E, Scailteux LM, Balusson F, Hascoet J, Alimi Q, Khene ZE, Bayat S, Jezequel M, Olivari C, Voiry C, Kerdraon J, Bouguen G, Game X, Siproudhis L, Manunta A.

Urology. 2019 Nov 14. pii: S0090-4295(19)30976-8. doi: 10.1016/j.urology.2019.11.006. [Epub ahead of print]

PMID:
31734348
2.

Management of aortic valve replacement according to the gradient across symptomatic aortic valve stenosis and its prognostic impact.

Bridonneau V, Galli E, Auffret V, Lederlin M, Campion M, Le Breton H, Boulmier D, Hubert A, Lenz PA, Leclercq C, Oger E, Donal E.

Echocardiography. 2019 Dec;36(12):2136-2144. doi: 10.1111/echo.14531. Epub 2019 Nov 8.

PMID:
31705575
3.
4.

Isotretinoin and risk factors for suicide attempt: a population-based comprehensive case series and nested case-control study using 2010-2014 French Health Insurance Data.

Droitcourt C, Poizeau F, Kerbrat S, Balusson F, Drezen E, Happe A, Travers D, Oger E, Dupuy A.

J Eur Acad Dermatol Venereol. 2019 Oct 6. doi: 10.1111/jdv.16005. [Epub ahead of print]

PMID:
31587374
5.

Concordance of severity scores for photographic assessment of hidradenitis suppurativa.

Prouteau C, Dinulescu M, Oger E, Pruvost-Balland C, Buche S, Cogrel O, Delage M, Maruani A, Nicol I, Sbidian E, Villani AP, Viguier M, Chastagner M, Grodner C, Kaoutar J, Laurent C, Leducq S, Dupuy A, Droitcourt C; Groupe thématique HS-France de la Société Française de Dermatologie.

Br J Dermatol. 2019 Sep 8. doi: 10.1111/bjd.18480. [Epub ahead of print] No abstract available.

PMID:
31494929
6.

Plant Small RNAs: A New Technology for Skin Care.

Oger E, Mur L, Lebleu A, Bergeron L, Gondran C, Cucumel K.

J Cosmet Sci. 2019 May/Jun;70(3):115-126.

PMID:
31398100
7.

Trends in sodium valproate prescriptions among children aged 0 to 14 years between 2010 and 2016: A study based on the French National Health Insurance Database.

Polard E, Degremont A, Rault C, Le Nautout B, Oger E, Biraben A, Nowak E.

Seizure. 2019 Aug;70:71-76. doi: 10.1016/j.seizure.2019.07.007. Epub 2019 Jul 8.

PMID:
31302303
8.

Early discharge in selected patients with low-grade renal trauma.

Freton L, Scailteux LM, Hutin M, Olivier J, Langouet Q, Ruggiero M, Dominique I, Millet C, Bergerat S, Panayatopoulos P, Betari R, Matillon X, Chebbi A, Caes T, Patard PM, Szabla N, Brichart N, Boehm A, Sabourin L, Guleryuz K, Dariane C, Lebacle C, Rizk J, Gryn A, Madec FX, Nouhaud FX, Rod X, Oger E, Fiard G, Bensalah K, Pradere B, Peyronnet B; TRAUMAFUF Collaborative Group.

World J Urol. 2019 Jun 28. doi: 10.1007/s00345-019-02855-y. [Epub ahead of print]

PMID:
31254097
9.

Risk of suicide attempt associated with isotretinoin: a nationwide cohort and nested case-time-control study.

Droitcourt C, Nowak E, Rault C, Happe A, Le Nautout B, Kerbrat S, Balusson F, Poizeau F, Travers D, Sapori JM, Lagarde E, Rey G, Guillot B, Oger E, Dupuy A.

Int J Epidemiol. 2019 Oct 1;48(5):1623-1635. doi: 10.1093/ije/dyz093.

10.

Do Patients With Acute Heart Failure and Preserved Ejection Fraction Have Heart Failure at Follow-Up: Implications of the Framingham Criteria.

Hage C, Löfström U, Donal E, Oger E, Kapłon-Cieślicka A, Daubert JC, Linde C, Lund LH.

J Card Fail. 2019 Apr 26. pii: S1071-9164(19)30019-3. doi: 10.1016/j.cardfail.2019.04.013. [Epub ahead of print]

PMID:
31035008
11.

A new phototherapy regimen during winter as an add-on therapy, coupled with oral vitamin D supplementation, for the long-term control of atopic dermatitis: study protocol for a multicentre, randomized, crossover, pragmatic trial - the PRADA trial.

Droitcourt C, Barbarot S, Maruani A, Darrieux L, Misery L, Brenaut E, Adamski H, Chabbert C, Vermersch A, Weiborn M, Seneschal J, Taïeb A, Plantin P, Maillard H, Phan A, Skowron F, Viguier M, Staumont-Salle D, Nosbaum A, Soria A, Barbaud A, Oger E, Dupuy A; Groupe de Recherche sur l’Eczéma Atopique de la Société Française de Dermatologie (GREAT).

Trials. 2019 Mar 25;20(1):184. doi: 10.1186/s13063-019-3276-9.

12.

French administrative health care database (SNDS): The value of its enrichment.

Scailteux LM, Droitcourt C, Balusson F, Nowak E, Kerbrat S, Dupuy A, Drezen E, Happe A, Oger E.

Therapie. 2019 Apr;74(2):215-223. doi: 10.1016/j.therap.2018.09.072. Epub 2018 Oct 25.

13.

Importance of structural heart disease and diastolic dysfunction in heart failure with preserved ejection fraction assessed according to the ESC guidelines - A substudy in the Ka (Karolinska) Ren (Rennes) study.

Persson H, Donal E, Lund LH, Matan D, Oger E, Hage C, Daubert JC, Linde C; KaRen Investigators.

Int J Cardiol. 2019 Jan 1;274:202-207. doi: 10.1016/j.ijcard.2018.06.078. Epub 2018 Jun 20.

14.

Use of 5α-reductase inhibitors for benign prostate hypertrophy and risk of high grade prostate cancer: a French population-based study.

Scailteux LM, Rioux-Leclercq N, Vincendeau S, Balusson F, Nowak E, Oger E; Network of Pathologists in Brittany.

BJU Int. 2019 Feb;123(2):293-299. doi: 10.1111/bju.14495. Epub 2018 Sep 11.

15.

Safety of Oral Propranolol for Infantile Hemangioma.

Droitcourt C, Kerbrat S, Rault C, Botrel MA, Happe A, Garlantezec R, Guillot B, Schleich JM, Oger E, Dupuy A.

Pediatrics. 2018 Jun;141(6). pii: e20173783. doi: 10.1542/peds.2017-3783.

16.

Predicting morbidity after robotic partial nephrectomy: The effect of tumor, environment, and patient-related factors.

Khene ZE, Peyronnet B, Kocher NJ, Robyak H, Robert C, Pradere B, Oger E, Kammerer-Jacquet SF, Verhoest G, Rioux-Leclercq N, Mathieu R, Raman JD, Bensalah K.

Urol Oncol. 2018 Jul;36(7):338.e19-338.e26. doi: 10.1016/j.urolonc.2018.04.005.

PMID:
29759510
17.

Intensive haemodialysis using PMMA dialyser does not increase renal response rate in multiple myeloma patients with acute kidney injury.

Hudier L, Decaux O, Haddj-Elmrabet A, Lino M, Mandart L, Siohan P, Renaudineau E, Sawadogo T, Lamy De La Chapelle T, Oger E, Bridoux F, Vigneau C.

Clin Kidney J. 2018 Apr;11(2):230-235. doi: 10.1093/ckj/sfx079. Epub 2017 Aug 22.

18.

Corrigendum to "Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study" [Int. J. Cardiol. 226 (2017) 65-70].

Savarese G, Donal E, Hage C, Oger E, Persson H, Daubert JC, Linde C, Lund LH; KaRen investigators.

Int J Cardiol. 2018 Jun 15;261:240. doi: 10.1016/j.ijcard.2018.03.075. Epub 2018 Mar 27. No abstract available.

PMID:
29602583
19.

Editorial.

Oger E.

Fundam Clin Pharmacol. 2018 Feb;32(1):77. doi: 10.1111/fcp.12341. No abstract available.

PMID:
29341301
20.

Sharing Health Big Data for Research - A Design by Use Cases: The INSHARE Platform Approach.

Bouzillé G, Westerlynck R, Defossez G, Bouslimi D, Bayat S, Riou C, Busnel Y, Le Guillou C, Cauvin JM, Jacquelinet C, Pladys P, Oger E, Stindel E, Ingrand P, Coatrieux G, Cuggia M.

Stud Health Technol Inform. 2017;245:303-307.

PMID:
29295104
21.

Pirfenidone photosensitization in patients with idiopathic pulmonary fibrosis: a case series.

Droitcourt C, Adamski H, Polat A, Polard E, Kerjouan M, Arnouat B, Le Garrec M, Oger E, Dupuy A, Jouneau S.

Br J Dermatol. 2018 Mar;178(3):e222-e223. doi: 10.1111/bjd.16016. Epub 2018 Jan 30. No abstract available.

22.

Periodontal status and serum biomarker levels in HFE haemochromatosis patients. A case-series study.

Meuric V, Lainé F, Boyer E, Le Gall-David S, Oger E, Bourgeois D, Bouchard P, Bardou-Jacquet E, Turmel V, Bonnaure-Mallet M, Deugnier Y.

J Clin Periodontol. 2017 Sep;44(9):892-897. doi: 10.1111/jcpe.12760. Epub 2017 Aug 17.

23.

Androgen deprivation therapy and cardiovascular risk: No meaningful difference between GnRH antagonist and agonists-a nationwide population-based cohort study based on 2010-2013 French Health Insurance data.

Scailteux LM, Vincendeau S, Balusson F, Leclercq C, Happe A, Le Nautout B, Polard E, Nowak E, Oger E.

Eur J Cancer. 2017 May;77:99-108. doi: 10.1016/j.ejca.2017.03.002. Epub 2017 Apr 5.

PMID:
28390298
24.

Importance of combined left atrial size and estimated pulmonary pressure for clinical outcome in patients presenting with heart failure with preserved ejection fraction.

Donal E, Lund LH, Oger E, Bosseau C, Reynaud A, Hage C, Drouet E, Daubert JC, Linde C; KaRen Investigators.

Eur Heart J Cardiovasc Imaging. 2017 Jun 1;18(6):629-635. doi: 10.1093/ehjci/jex005.

PMID:
28329385
25.

Pre- and postoperative tricuspid regurgitation in patients with severe symptomatic aortic stenosis: importance of pre-operative tricuspid annulus diameter.

Dumont C, Galli E, Oger E, Fournet M, Flecher E, Leclercq C, Verhoye JP, Donal E.

Eur Heart J Cardiovasc Imaging. 2018 Mar 1;19(3):319-328. doi: 10.1093/ehjci/jex031.

PMID:
28329333
26.

[Impact of robotic assistance on the use and the outcomes of nephron-sparing surgery: A single center experience].

Fardoun T, Peyronnet B, Oger E, Verhoest G, Mathieu R, Khene Z, Pradere B, Alimi Q, Manunta A, Rioux-Leclercq N, Patard JJ, Kammerer-Jacquet SF, Bensalah K.

Prog Urol. 2016 Dec;26(16):1163-1170. doi: 10.1016/j.purol.2016.09.074. Epub 2016 Oct 27. French.

PMID:
28279366
27.

The prognostic significance of atrial fibrillation in heart failure with preserved ejection function: insights from KaRen, a prospective and multicenter study.

Bosseau C, Donal E, Lund LH, Oger E, Hage C, Mulak G, Daubert JC, Linde C; KaRen investigators.

Heart Vessels. 2017 Jun;32(6):735-749. doi: 10.1007/s00380-016-0933-8. Epub 2016 Dec 27.

PMID:
28028584
28.

Is Anticoagulation Discontinuation Achievable with Citrate Dialysate during HDF Sessions?

Dolley-Hitze T, Oger E, Hamel D, Lombart ML, Hermès I.

Int J Nephrol. 2016;2016:9185413. Epub 2016 Oct 10.

29.

Comparison of 1800 Robotic and Open Partial Nephrectomies for Renal Tumors.

Peyronnet B, Seisen T, Oger E, Vaessen C, Grassano Y, Benoit T, Carrouget J, Pradère B, Khene Z, Giwerc A, Mathieu R, Beauval JB, Nouhaud FX, Bigot P, Doumerc N, Bernhard JC, Mejean A, Patard JJ, Shariat S, Roupret M, Bensalah K; French Comittee of Urologic Oncology (CCAFU).

Ann Surg Oncol. 2016 Dec;23(13):4277-4283. Epub 2016 Jul 13.

PMID:
27411552
30.

Changes in natriuretic peptides after acute hospital presentation for heart failure with preserved ejection fraction: A feasible surrogate trial endpoint? A report from the prospective Karen study.

Savarese G, Donal E, Hage C, Oger E, Persson H, Daubert JC, Linde C, Lund LH; KaRen investigators.

Int J Cardiol. 2017 Jan 1;226:65-70. doi: 10.1016/j.ijcard.2016.10.035. Epub 2016 Oct 17. Erratum in: Int J Cardiol. 2018 Mar 27;:.

PMID:
27788392
31.

[Patient's preferences for repeat prescriptions in general practice].

Siproudhis J, Chapron A, Allory E, Fiquet L, Dauguet S, Oger E.

Therapie. 2016 Dec;71(6):579-587. doi: 10.1016/j.therap.2016.04.007. Epub 2016 Jul 21. French.

PMID:
27663121
32.
33.

Postmenopausal Hormone Therapy and Risk of Stroke: Impact of the Route of Estrogen Administration and Type of Progestogen.

Canonico M, Carcaillon L, Plu-Bureau G, Oger E, Singh-Manoux A, Tubert-Bitter P, Elbaz A, Scarabin PY.

Stroke. 2016 Jul;47(7):1734-41. doi: 10.1161/STROKEAHA.116.013052. Epub 2016 Jun 2.

34.

Safety and Feasibility of Laparoscopic Nephrectomy for Big Tumors (≥ 10 cm): A Retrospective Multicentric Study.

Verhoest G, Couapel JP, Oger E, Rioux-Leclercq N, Pignot G, Patard JJ, Bex A, Panayotopoulos P, Bigot P, Eret V, Hora M, Turna B, Lefevre M, Rigaud J, Tillou X, Doerfler A, Xylinas E, Soorojebally Y, Rouprêt M, Lagabrielle S, Bernhard JC, Long JA, Berger J, Ravier E, Paparel P, Salomon L, Rodriguez AR, Bensalah K.

Clin Genitourin Cancer. 2016 Aug;14(4):e335-40. doi: 10.1016/j.clgc.2016.01.007. Epub 2016 Jan 27.

35.

Letter to the Editor: "Transdermal vs Oral Estrogen Therapy and Venous Thromboembolism: Upgrade the Level of Evidence" by.

Scarabin PY, Canonico M, Scarabin-Carré V, Oger E.

J Clin Endocrinol Metab. 2016 Feb;101(2):L30-1. doi: 10.1210/jc.2015-4248. No abstract available.

PMID:
26840115
36.

Safety of Fixed Dose of Antihypertensive Drug Combinations Compared to (Single Pill) Free-Combinations: A Nested Matched Case-Control Analysis.

Nowak E, Happe A, Bouget J, Paillard F, Vigneau C, Scarabin PY, Oger E.

Medicine (Baltimore). 2015 Dec;94(49):e2229. doi: 10.1097/MD.0000000000002229.

37.

Opinion of French nephrologists on renal replacement therapy: survey on their personal choice.

Lorcy N, Turmel V, Oger E, Couchoud C, Vigneau C.

Clin Kidney J. 2015 Dec;8(6):785-8. doi: 10.1093/ckj/sfv093. Epub 2015 Oct 14.

38.

Emergency admissions for major haemorrhage associated with direct oral anticoagulants.

Bouget J, Oger E.

Thromb Res. 2015 Dec;136(6):1190-4. doi: 10.1016/j.thromres.2015.10.036. Epub 2015 Oct 29.

PMID:
26545315
39.

Safety of prasugrel in real-world patients with ST-segment elevation myocardial infarction: 1-year results from a prospective observational study (Bleeding and Myocardial Infarction Study).

Bacquelin R, Oger E, Filippi E, Hacot JP, Auffret V, Le Guellec M, Coudert I, Castellant P, Moquet B, Druelles P, Rialan A, Rouault G, Boulanger B, Treuil J, Leurent G, Bedossa M, Boulmier D, Avez B, Gilard M, Le Breton H.

Arch Cardiovasc Dis. 2016 Jan;109(1):31-8. doi: 10.1016/j.acvd.2015.08.005. Epub 2015 Oct 26.

40.

Electrocardiographic correlates of mechanical dyssynchrony in recipients of cardiac resynchronization therapy devices.

Behaghel A, Brunet-Bernard A, Oger E, Martins R, Donal E, Fournet M, Feneon D, Leclercq C, Mabo P, Daubert C.

Arch Cardiovasc Dis. 2015 Dec;108(12):617-25. doi: 10.1016/j.acvd.2015.06.007. Epub 2015 Oct 20.

41.

L'Ischémie n'est pas un facteur d'insuffisance rénale chronique après néphrectomie partielle sur rein unique.

Pignot G, Bahi R, Bensalah K, Oger E, Laguna P, Barwari K, Rigaud J, Rouprêt M, Bernhard J, Long J, Zisman A, Berger J, Paparel P, Lechevallier E, Bertini R, Salomon L, Bex A, Farfara R, Ljungberg B, Rodriguez A, Patard J.

Prog Urol. 2014 Nov;24(13):822. doi: 10.1016/j.purol.2014.08.087. Epub 2014 Oct 30. French. No abstract available.

PMID:
26461614
42.

Brand name to generic substitution of antiepileptic drugs does not lead to seizure-related hospitalization: a population-based case-crossover study.

Polard E, Nowak E, Happe A, Biraben A, Oger E; GENEPI Study Group.

Pharmacoepidemiol Drug Saf. 2015 Nov;24(11):1161-9. doi: 10.1002/pds.3879. Epub 2015 Sep 23.

43.

Value of exercise echocardiography in heart failure with preserved ejection fraction: a substudy from the KaRen study.

Donal E, Lund LH, Oger E, Reynaud A, Schnell F, Persson H, Drouet E, Linde C, Daubert C; KaRen investigators.

Eur Heart J Cardiovasc Imaging. 2016 Jan;17(1):106-13. doi: 10.1093/ehjci/jev144. Epub 2015 Jun 16.

PMID:
26082167
44.

New echocardiographic predictors of clinical outcome in patients presenting with heart failure and a preserved left ventricular ejection fraction: a subanalysis of the Ka (Karolinska) Ren (Rennes) Study.

Donal E, Lund LH, Oger E, Hage C, Persson H, Reynaud A, Ennezat PV, Bauer F, Drouet E, Linde C, Daubert C; KaRen investigators.

Eur J Heart Fail. 2015 Jul;17(7):680-8. doi: 10.1002/ejhf.291. Epub 2015 May 29.

45.

The use of hemostatic agents does not prevent hemorrhagic complications of robotic partial nephrectomy.

Peyronnet B, Oger E, Khene Z, Verhoest G, Mathieu R, Roumiguié M, Beauval JB, Pradere B, Masson-Lecomte A, Vaessen C, Baumert H, Bernhard JC, Doumerc N, Droupy S, Bruyere F, De La Taille A, Roupret M, Bensalah K.

World J Urol. 2015 Nov;33(11):1815-20. doi: 10.1007/s00345-015-1537-0. Epub 2015 Mar 29.

PMID:
25820610
46.

Prognostic and predictive values of oncogenic BRAF, NRAS, c-KIT and MITF in cutaneous and mucous melanoma.

Pracht M, Mogha A, Lespagnol A, Fautrel A, Mouchet N, Le Gall F, Paumier V, Lefeuvre-Plesse C, Rioux-Leclerc N, Mosser J, Oger E, Adamski H, Galibert MD, Lesimple T.

J Eur Acad Dermatol Venereol. 2015 Aug;29(8):1530-8. doi: 10.1111/jdv.12910. Epub 2015 Jan 26.

PMID:
25623140
47.

[Impact of a regional pharmacovigilance network on notification of adverse drug reactions: results at 3 years].

Picard S, Polard E, Oger E, Bellissant E.

Therapie. 2015 May-Jun;70(3):293-9. doi: 10.2515/therapie/2014216. Epub 2014 Dec 24. French.

PMID:
25534522
48.

Is home blood pressure monitoring feasible and well accepted in nephrectomized patients for renal cancer? (STAFF study).

Lorcy N, Dourmap-Collas C, Lafourcade A, Le Stum S, Victor B, Donal E, Laguerre B, Verhoest G, Oger E, Vigneau C.

Blood Press. 2015 Apr;24(2):86-9. doi: 10.3109/08037051.2014.986932. Epub 2014 Dec 22.

PMID:
25531211
49.

Follow-up of post-transplant minimal residual disease and chimerism in childhood lymphoblastic leukaemia: 90 d to react.

Pochon C, Oger E, Michel G, Dalle JH, Salmon A, Nelken B, Bertrand Y, Cavé H, Cayuela JM, Grardel N, Macintyre E, Margueritte G, Méchinaud F, Rohrlich P, Paillard C, Demeocq F, Schneider P, Plantaz D, Poirée M, Eliaou JF, Semana G, Drunat S, Jonveaux P, Bordigoni P, Gandemer V.

Br J Haematol. 2015 Apr;169(2):249-61. doi: 10.1111/bjh.13272. Epub 2014 Dec 19.

PMID:
25522886
50.

Emergency admissions for major haemorrhage associated with antithrombotics: a cohort study.

Bouget J, Oger E, Nicolas N.

Thromb Res. 2015 Jan;135(1):84-9. doi: 10.1016/j.thromres.2014.10.029. Epub 2014 Nov 5.

Supplemental Content

Support Center